Walleye Capital

Walleye Capital’s Atara Biotherapeutics ATRA Stock Holding History

Walleye Capital’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,169	Closed	-$220K	–	4377
2025 Q4	$220K	Buy	+12,169	New	+$182K	﹤0.01%	3493
2023 Q2	–	Sell	-3,536	Closed	-$256K	–	4297
2023 Q1	$256K	Sell	3,536 -4,116	-54%	-$399K	﹤0.01%	2252
2022 Q4	$627K	Sell	7,652 -7,388	-49%	-$770K	0.01%	1310
2022 Q3	$1.42M	Buy	+15,040	New	+$1.69M	0.03%	739
2022 Q2	–	Sell	-1,274	Closed	-$296K	–	2349
2022 Q1	$296K	Buy	+1,274	New	+$406K	0.01%	1316
2020 Q1	–	Sell	-408	Closed	-$168K	–	930
2019 Q4	$168K	Buy	+408	New	+$141K	0.01%	1191

Other funds holding ATRA

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Mackenzie Financial

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return